Related Experiment Video
Updated: May 15, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis
Francesco Ferrini1, Tuan Trang, Theresa-Alexandra M Mattioli
1Institut Universitaire en Santé Mentale de Québec, Québec, Canada.
Abstract:
A major unresolved issue in treating pain is the paradoxical hyperalgesia produced by the gold-standard analgesic morphine and other opiates. We found that hyperalgesia-inducing treatment with morphine resulted in downregulation of the K(+)-Cl(-) co-transporter KCC2, impairing Cl(-) homeostasis in rat spinal lamina l neurons. Restoring the anion equilibrium potential reversed the morphine-induced hyperalgesia without affecting tolerance. The hyperalgesia was also reversed by ablating spinal microglia. Morphine hyperalgesia, but not tolerance, required micro opioid receptor-dependent expression of P2X4 receptors (P2X4Rs) in microglia and micro-independent gating of the release of brain-derived neurotrophic factor (BDNF) by P2X4Rs. Blocking BDNF-TrkB signaling preserved Cl(-) homeostasis and reversed the hyperalgesia. Gene-targeted mice in which Bdnf was deleted from microglia did not develop hyperalgesia to morphine. However, neither morphine antinociception nor tolerance was affected in these mice. Our findings dissociate morphine-induced hyperalgesia from tolerance and suggest the microglia-to-neuron P2X4-BDNF-KCC2 pathway as a therapeutic target for preventing hyperalgesia without affecting morphine analgesia.
Insights
Morphine causes pain hypersensitivity by disrupting chloride balance in neurons. Targeting the microglial P2X4-BDNF-KCC2 pathway can prevent this, without impacting pain relief or tolerance.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Morphine, a standard pain reliever, paradoxically causes hyperalgesia (increased pain sensitivity).
- The mechanisms underlying morphine-induced hyperalgesia remain unclear.
- Opioid-induced hyperalgesia presents a significant challenge in pain management.
Purpose of the Study:
- To investigate the cellular and molecular mechanisms of morphine-induced hyperalgesia.
- To identify therapeutic targets for preventing hyperalgesia while preserving analgesia.
- To differentiate the mechanisms of hyperalgesia from opioid tolerance.
Main Methods:
- Used rat models and gene-targeted mice to study morphine effects.
- Examined the role of KCC2 transporter, chloride homeostasis, and spinal microglia.
- Investigated microglial P2X4 receptors (P2X4Rs) and brain-derived neurotrophic factor (BDNF) signaling.
Main Results:
- Morphine treatment downregulated KCC2, impairing neuronal chloride homeostasis and causing hyperalgesia.
- Hyperalgesia was reversed by restoring chloride balance or ablating microglia.
- The P2X4-BDNF pathway in microglia was crucial for hyperalgesia but not tolerance.
- Blocking BDNF signaling prevented hyperalgesia without affecting analgesia or tolerance.
Conclusions:
- Morphine-induced hyperalgesia is dissociable from analgesic tolerance.
- The microglia-neuron P2X4-BDNF-KCC2 pathway is a key mediator of hyperalgesia.
- This pathway represents a potential therapeutic target for managing opioid-induced hyperalgesia.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Nociception
Pain
